What ?? House Democrats Weighing Action

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
210
What ??

House Democrats Weighing Action [url=]https://www.breitbart.com/middle-east/2019/08/18/house-democrats-weighing-action-of-israeli-us-envoys-over-tlaib-omar-ban/< >[/url]
Against Israeli, U.S. Envoys over Tlaib, Omar Ban
https://investorshangout.com/post/newpost/91602/
31gcqd_budget-battle-37863-nancy-pelosi-steny-hoyer-joseph-crowley-linda-sanchez-420x280.jpg

Senior Democratic members of Congress are said to have launched discussions to formally censure the U.S. Ambassador to Israel and Jerusalem’s envoy in Washington over Israel’s decision to bar entry to congresswomen Rashida Tlaib and Ilhan Omar.

Around a dozen lawmakers, several of whom are Jewish, have begun talks to communicate a “deep lack of confidence and trust” in Israel’s ambassador to the U.S. Ron Dermer and U.S. envoy to Israel David Friedman, the McClatchy news service reported, citing congressional sources.

According to the report, the Democrats are considering releasing a statement of no confidence in Dermer and opening an inspector-general investigation into Friedman.

Among the twelve are House Foreign Affairs Committee Chairman Eliot Engel and House Appropriations Committee Chairwoman Nita Lowey, two Jewish lawmakers from New York.

“We are reviewing all of our options,” McClatchy quoted a source as saying. “With Dermer, the issue is that there already was a severe lack of trust. But now there is a severe lack of confidence. It is completely unclear that he represents his government given he has made promises that he has not kept and wasn’t clear if he ever had any chance of keeping.”

Last month, Dermer assured lawmakers that Omar and Tlaib — open supporters of the Boycott, Divestment and Sanctions (BDS) movement against Israel — would be allowed into Israel “out of respect for Congress.”

However, on Thursday, Israel said the two would be denied entry.

Prime Minister Benjamin Netanyahu, in a statement defending the decision to bar entry to Omar and Tlaib, said the two intended to use the visit to harm Israel.

“Several days ago, we received [Omar and Tlaib’s] trip itinerary,” Netanyahu said, “which clarified that they planned a visit whose sole purpose was to support boycotts and deny Israel’s legitimacy. For example, they called their destination ‘Palestine’ and not ‘Israel,’ and unlike all Democratic and Republican members of Congress before them, they did not seek any meeting with any Israeli official, whether government or opposition.”

On Friday, Omar claimed that she had planned to meet with Knesset members and security officials, although the jam-packed itinerary — released days before their planned visit — showed otherwise.

The trip, according to the itinerary, would be based exclusively in the Palestinian territories with the exception of the first day that would take place in the primarily Arab-populated eastern area of Jerusalem. The two were slated to meet only with Palestinian officials as well as representatives from human rights groups and other organizations.

The congresswomen were scheduled to meet with representatives from Palestinian groups Miftah, a sponsor of the trip, and the Defense for Children International-Palestine (DCI-P), groups that have endorsed terrorism and have ties to terror organizations.

“In addition, the organization that is funding their trip is Miftah, which is an avid supporter of BDS, and among whose members are those who have expressed support for terrorism against Israel,” Netanyahu said.

The prime minister said that Tlaib was welcome to apply to visit on humanitarian grounds to see her family, with the caveat that she not engage in promoting boycotts of Israel while in the country. Tlaib acquiesced, and quickly received permission to visit. However, she changed her mind hours later, saying that coming to Israel on its terms would be “humiliating” and she would not “bow down to their oppressive & racist policies.”

House Majority Leader Steny Hoyer, who recently led a large Democratic delegation to Israel, issued a statement Thursday censuring Israel over the decision and said it contradicted what he and others had been told by Dermer.

McClatchy quoted the source as saying, “Dermer is saying privately that he expects this to go away within a day — it’s a real lack of understanding on the consequences of this.”

In the discussions Friday, the lawmakers raised an incident in 1975 in which Henry Waxman, a longtime Democratic congressman from California, was initially banned from Saudi Arabia for his Jewish roots. He was eventually granted entry following pressure from the State Department.

Friedman’s endorsement of Israel’s decision to bar Omar and Tlaib’s entry into the country broke with that precedent, they argued, and as a result called for an investigation “into the role the ambassador played in barring them from entering the country,” the report quoted another congressional source as saying.

The decision to bar the two Muslim lawmakers from entering Israel came shortly after President Donald Trump wrote on Twitter that, in doing so, Israel would be showing “great weakness.”

Both Trump and Dermer have denied that the president pressured Israel into backtracking.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

DraftKings Faces Revenue Cutback; Legal Probe Begins

Updated Category News Views 103

DraftKings' Surprising Turn of Fortune Talk about a gut punch! DraftKings (NASDAQ: DKNG) dropped a bombshell that had investors reeling. They decided to lop off a hefty slice of their revenue guidance, and trust me, those aren't small numbers we’re talking about. On November 6, they yanked their full-year 2026 revenue guidance down to $6.35 billion to $6.55 billion from...

Continue Reading
Andersen's Window Revamp: Addressing Demand Surge

Updated Category News Views 96

Portfolio Boost: Adapting to Market Needs If you're sniffing around the windows business, there's a fresh breeze of innovation blowing from Andersen. They're not just sitting around drumming their fingers—they're rolling up their sleeves and fine-tuning their offerings. With half of homeowners swinging a hammer on renovations last year, the company sees an opportunity...

Continue Reading
Tenax Therapeutics Faces Legal Heat After Stock Plunge

Updated Category News Views 92

Investors' Nerves Tested as Tenax Takes a Nosedive Holy smokes! When a biotech company like Tenax Therapeutics, Inc. (NASDAQ: TENX) detonates like a forgotten fireworks stash, investors have every right to get itchy. Tenax’s shocking announcement that their Phase 3 LEVEL trial for TNX-103 flopped has sparked more than just shareholder anxiety. It’s ignited a...

Continue Reading
212NYC Gala Celebrates Ad Industry's Human Touch

Updated Category News Views 157

The Advertising Gala with Heart When you toss nearly 300 advertising honchos into a room at Tribeca's Rooftop, you don't just get another bash; you get an industry checkpoint. This time, the 212NYC shindig on November 5, 2026, wasn't just about stroking egos. It was about spotlighting the soul in business, right when AI threatens to run wild with it. Navigating AI's...

Continue Reading
Pete Crow-Armstrong Unveils Signature Baseball Gloves

Updated Category News Views 83

The Windy City Meets the Diamond Alright, bear with me here. Monday morning vibes, right? But here's something that'll turn your breakfast around if you're into baseball—or just the latest scoop on players making waves in gear. Pete Crow-Armstrong, the Chicago Cubs center fielder who's been lighting up the field, has his name on some fresh gear. We're talking signature...

Continue Reading
PAC Criticizes JD Vance's Billionaire Connections

Updated Category News Views 107

Unveiling Vance's High-Powered Backers Brace yourself for a fresh round of political sparring, folks. The Patriots for American Principles PAC has decided that JD Vance's relationships with the billionaire elite need a little more sunshine. And they're not shy about it—Vance's billionaires will be paraded around the streets of Washington D.C. on a mobile billboard,...

Continue Reading
Koppers Navigates Q3: Margins Squeeze Amid Growth

Updated Category News Views 123

Investing in Koppers: A Mixed Bag in Q3 Well, it appears Koppers (NYSE: KOP) is doing a bit of a dance this quarter—some smooth steps, but a few stumbles in the rhythm when it comes to margins. The hardwood numbers tell an interesting tale, so let's break it down. Sales Edge Up, But Margins Suffer Koppers clocked in net sales of $499.1 million for the third quarter of...

Continue Reading
Precision Biologics Unveils Promising Data on PB-223

Updated Category News Views 95

Precision's Big Reveal at SITC 2026 When it comes to the shifting tides of oncology advancements, Precision Biologics is making some serious waves. They're not leaning back; they're diving right in with their latest showcase at the Society for Immunotherapy of Cancer (SITC) Annual Meeting, 2026. CEO Dr. Philip M. Arlen announced compelling preclinical data for their...

Continue Reading
Everest Group Faces Class Action: Key Investor Moves

Updated Category News Views 117

Everest Group's Legal Spiral: What's Happening? Folks, when a company feels like it's caught in an endless storm, investors better hold on tight. That's the situation Everest Group, Ltd. finds itself in, with an 11.4% stock dive that’s got investors reeling. Securities fraud allegations are rocking Everest like a hurricane, and The Law Offices of Frank R. Cruz have put...

Continue Reading
OncoC4's Cesalatamig: Promising Results in NSCLC Trials

Updated Category News Views 85

Hope in Persistence: Cesalatamig in the Spotlight Swinging through the medical landscape like a seasoned fighter, OncoC4's recent revelations at the SITC 2026 give investors and doctors a reason to pay close attention. We're sizing up their investigational drug, cesalatamig, which flaunts a solid objective response rate of 33% among non-small cell lung cancer (NSCLC)...

Continue Reading

Top 5 Most Recently Viewed Articles

Shipley Donuts Expands to Vienna, Delight in Every Bite

Updated Category News Views 73

Shipley Donuts: A Sweet Texas Tradition Lands in Virginia The donut world just got a little tastier in Northern Virginia as Shipley Donuts, that iconic Texan sweetheart, opened shop in Vienna. We're talking handmade donuts, done the old-school way, with a taste that makes you wanna grab a dozen before work. They’ve been crafting this magic for nearly a century, starting...

Continue Reading
Volato's Strategic Expansion with Gulfstream G280 Deliveries

Updated Category News Views 224

Volato's Exciting Addition to Its Fleet Volato Group, Inc. (the "Company" or "Volato") (NYSE American: SOAR), a frontrunner in private aviation, is thrilled to announce a significant milestone: the delivery of its second Gulfstream G280 is set for January 2025. This delivery is part of a strategic order of four aircraft and underscores the company’s proactive approach...

Continue Reading
Velico's Partnership with South Texas Blood Center Revolutionizes Plasma Access

Updated Category News Views 355

Transforming Plasma Access with Innovative Technology In a historic move, the South Texas Blood and Tissue Center (STBT) has become the first civilian blood center in the U.S. to adopt Velico, Inc.'s revolutionary FrontlineODP™ system. This groundbreaking partnership aims to enhance emergency medical practices by providing on-demand spray-dried plasma, making...

Continue Reading
The Incredible Growth of Teradyne: A Decade of Investment

Updated Category News Views 119

Investing in Teradyne: A Decade of Incredible Returns When it comes to long-term investments, certain stocks have consistently proven their worth. Teradyne (NASDAQ: TER) is one such company that has outperformed market expectations over the past decade. With an impressive annualized performance exceeding 11.62%, Teradyne has become a staple in many investors' portfolios....

Continue Reading
Grid Battery Metals Expands Copper Portfolio for Future Growth

Updated Category News Views 126

Grid Battery Metals' Exciting New Copper Acquisition Grid Battery Metals Inc. has made a significant move by acquiring a new copper project, broadening its portfolio in the battery metals sector. Tim Fernback, the President and CEO, articulated the strategic importance of this acquisition and its implications for future exploration activities. Strategic Location of the...

Continue Reading